Position in SRZN
as of Dec 31, 2025
· filed Feb 11, 2026
Position Value
$2,349,812
New position
Shares Held
103,974
first reported quarter
Ownership
0.896%
of shares outstanding
% of Portfolio
1.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Empery Asset Management, LP holds $53,120,730 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XFOR |
X4 Pharmaceuticals, Inc
|
8,944,118 | $36,939,207 | |
| 2 | DTIL |
Precision Biosciences Inc
|
1,968,879 | $10,828,834 | |
| 3 | TNYA |
Tenaya Therapeutics, Inc.
|
4,286,933 | $2,966,557 | |
| 4 | MSLE |
Satellos Bioscience Inc.
|
230,100 | $1,295,463 | |
| 5 | PMN |
ProMIS Neurosciences Inc.
|
60,353 | $766,483 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
30,440 | $324,186 |
All Filings in SRZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2,349,812 | 103,974 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||